NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ARIZ Precision Medicine

ARIZ Precision Medicine

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://arizbio.com/

Last Round

Angel

Nov 21, 2024

Total Funding Raised

$795,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ARIZ Precision Medicine is a biotechnology company that develops a precision medicine platform designed to create targeted cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyCAR-T therapymultiple myelomaoncologyautologous CAR-TCD38 targetingcell and gene therapyCGTmulti-cistronic vectorprecision medicineclinical-stage biotechvector platformpre-revenue biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ARIZ Precision Medicine Comparables

Compare ARIZ Precision Medicine with similar companies based on industry and business-model similarity.

ARIZ Precision Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

ARIZ Precision Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelNov 21, 2024
GrantJul 11, 2024
SeedOct 28, 2020

Key People

Founding team and executive leadership

Brad Niles

CEO

Executive Team

Lonnie Bookbinder

Founder, Founding CEO, Chairman Of The Board Of Directors

Founding Team

ARIZ Precision Medicine Investors

Notable investors and investment history

ARIZ Precision Medicine investors
InvestorRounds
Growth FactoryAngel
Moneta Venture CapitalSeed
BrightEdgeGrant
NorCal AngelConAngel
Bakar BioLabsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 72% MoM, reaching 1.9K.

  • Jan 31, 2026

    Monthly visitors grew 2707% MoM, from 59 to 1.7K.

ARIZ Precision Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ARIZ Precision Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ARIZ Precision Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersDavis, California
Employee Range2
Year Founded2015
Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.